Trial intelligence / Profile preview

DOROTHEO 1: doxofylline versus theophylline in asthma

ISRCTN65297911Phase 3Completed

Sponsor
Roberts Pharmaceutical
Start
Aug 1991
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of doxofylline and theophylline in asthma (4 arms), sponsored by Roberts Pharmaceutical. Primary endpoint: Forced expiratory volume in 1 second. Started Aug 1991; status: completed.

02

Drugs

doxofyllinetheophylline
03

Conditions

asthma

Beyond the preview

Go deeper on ISRCTN65297911.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN65297911.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call